Pneumococcal Infection and Immunization in Children

References

• Immunization Practices Advisory Committee. Pneumococcal polysaccharide vaccine. Mort. Morb. Wkly. Rep. 1989; 38: 64
   PubMedGoogle Scholar
• Williams W. W., Hickson M. A., Kane M. A., Kendal A. P., Spika J. S., Hinman A. R. Immunization policies and vaccine coverage among adults: the risk for missed opportunities. Ann. Intern. Med. 1988; 108: 616
   PubMed Web of Science ®Google Scholar
• Klein J. O. The epidemiology of pneumococcal disease in infants and children. Rev. Infect. Dis. 1981; 3: 246
   PubMedGoogle Scholar
• Teele D. W., Klein J. O., Rosner B. A. Epidemiology of otitis media in children. Ann. Otol. Rhinol. Laryngol. 1980; 89(Suppl. 68)5
   Web of Science ®Google Scholar
• Jacobs N. M., Lerkachornsuk S., Metzger W. L. Pneumococcal bacteremia in infants and children: a ten-year experience at the Cook County Hospital with special reference to the pneumococcal serotypes isolated. Pediatrics 1979; 64: 296
   PubMed Web of Science ®Google Scholar
• Austrian R. Pneumococcal infection. Bacterial Vaccines, R. Germanier. Academic Press, New York 1984; 257
   Google Scholar
• Austrian R. Epidemiology of pneumococcal capsular types causing pediatric infections. Pediatr. Infect. Dis. J. 1989; 8: S21
   Web of Science ®Google Scholar
• Eskola J., Takala A. K., Kela E., et al. Epidemiology of invasive pneumococcal infections in children in Finland. JAMA 1992; 268: 3323
   PubMed Web of Science ®Google Scholar
• Dagan R., Englehard D., Piccard E., et al. Epidemiology of invasive childhood pneumococcal infection in Israel. JAMA 1992; 268: 3328
   PubMed Web of Science ®Google Scholar
• Gray B. M., Dillon H. C., Jr. Clinical and epidemiologic studies of pneumococcal infection in children. Pediatr. Infect. Dis. J. 1986; 5: 201
   Web of Science ®Google Scholar
• Filice G. A., Darby C. P., Fraser D. W. Pneumococcal bacteremia in Charleston County, South Carolina. Am. J. Epidemiol. 1980; 112: 828
   PubMed Web of Science ®Google Scholar
• Breiman R. F., Spika J. S., Navarro V. J., Darden P. M., Darby C. P. Pneumococcal bacteremia in Charleston County, South Carolina: a decade later. Arch. Intern. Med. 1990; 150: 1401
   PubMedGoogle Scholar
• Teele D. W., Klein J. O., Rosner B. and the Greater Boston Otitis Media Study Group, Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study. J. Infect. Dis. 1989; 160: 83
   PubMed Web of Science ®Google Scholar
• Sloyer H. L., Jr., Ploussard J. H., Karr I. J., Schiffman G. D. Immunologic response to pneumococcal polysaccharide vaccine in infants. Ann. Owl. Rhinol. Laryngoi 1980; 89(Suppl. 68)351
   Google Scholar
• Makeia P. H., Sibakov M., Herva E., Henrichsen J., Luotonen J., Timonen M., Leinonen M., Koskela M., Pukander J., Pontynen S., Gronroos P., Karma P. Pneumococcal vaccine and otitis media. Lancet. 1980; 2: 547
   PubMed Web of Science ®Google Scholar
• Giebink G. S. The microbiology of otitis media. Pediatr. Infect. Dis. J. 1989; 8: S18
   PubMed Web of Science ®Google Scholar
• Johnston R. B. Pathogenesis of pneumococcal pneumonia. Rev. Infect. Dis. 1991; 13(Suppl. 6)S509
   PubMedGoogle Scholar
• Gray B. M., Converse G. M., III, Dillon H. C., Jr. Serotypes of Streptococcus pneumoniae causing disease. J. Infect. Dis. 1979; 140: 979
   PubMed Web of Science ®Google Scholar
• Austrian R., Howie V. M., Ploussard J. H. The bacteriology of pneumococcal otitis media. Johns Hopkins Med. J. 1977; 141: 104
   PubMedGoogle Scholar
• Nielsen S. V., Henrichsen J. Capsular types of Streptococcus pneumoniae isolated from blood and CSF during 1982–1987. Clin. Infect. Dis. 1992; 15: 794
   PubMed Web of Science ®Google Scholar
• Lamothe F., Delaage G., LaVerdiere M., Saint-Antoine P. Serogroups and serotypes of pneumococci in Montreal: correlations with age, outcome and indications for vaccination. Can. Med. Assoc. J. 1984; 130: 737
   PubMed Web of Science ®Google Scholar
• Jacobs N. M., Lerdkachornsuk S., Metzger W. I. Pneumococcal bacteremia in infants and children: a ten-year experience at the Cook County Hospital with special reference to the pneumococcal serotypes isolated. Pediatrics 1979; 64: 296
   PubMed Web of Science ®Google Scholar
• Siegel J. D., Poziviak C. S., Michaels R. H. Serotypically defined pneumococcal infections in children. J. Pediatr. 1978; 93: 249
   PubMed Web of Science ®Google Scholar
• Mufson M. A. Pneumococcal infections. JAMA 1981; 246: 1942
   PubMed Web of Science ®Google Scholar
• Quie P. G., Giebink G. S., Winkelstein J. A. The pneumococcus. Rev. Infect. Dis. 1981; 3: 183
   Google Scholar
• Van Furth R., Schuit H. R. E., Hijmans W. The immunological development of the human fetus. J. Exp. Med. 1965; 122: 1173
   PubMed Web of Science ®Google Scholar
• Morito T., Bankhurst A. D., Williams R. C., Jr. Studies of human cord blood and adult lymphocyte interactions with in vitro immunoglobulin production. J. Clin. Invest. 1979; 64: 990
   PubMed Web of Science ®Google Scholar
• Schlamowitz M. Membrane receptors in the specific transfer of immunoglobulins from mother to young. Immunol. Commun. 1976; 5: 481
   PubMed Web of Science ®Google Scholar
• Niezgodka M., Mikulska J., Ugorski M., Boratynski J., Lisowski J. Human placental membTane receptor for IgG. I. Studies on properties and solubilization of the receptor. Mol. Immunol. 1981; 18: 163
   PubMed Web of Science ®Google Scholar
• Brown P. J., Johnson P. M. Fc r-receptor activity on isolated human placental syncytiotrophoblast plasma membrane. Immunology 1981; 42: 313
   PubMed Web of Science ®Google Scholar
• Wild A. E. Endocytotic mechanisms in protein transfer across the placenta. Placenta 1980; 1(Suppl. 1)165
   Google Scholar
• Van der Meulen J. A., McNabb T. C., Haeffner-Cavaillon N., Klein M., Dorrington K. J. The Fc r-receptor on human placental plasma membrane. I. Studies on the binding of homologous and heterologous immunoglobulin G. J. Immunol. 1980; 124: 500
   PubMed Web of Science ®Google Scholar
• Koskela M., Leinonen M., Maiva V. M., Timonen M., Makela H. First and second dose antibody responses to pneumococcal polysaccharide vaccine in infants. Pediatr. Infect. Dis. J. 1986; 5: 45
   Web of Science ®Google Scholar
• Barrett D. J., Lee C G., Ammann A. J., Ayoub E. M. IgG and IgM pneumococcal polysaccharide antibody responses in infants. Pediatr. Res. 1984; 18: 1067
   PubMed Web of Science ®Google Scholar
• Borgono J. M., McLean A. A., Vella P. P., et al. Vaccination and revaccination with polyvalent pneumococcal polysaccharide vaccines in adults and infants. Proc. Soc. Exp. Biol. Med. 1978; 157: 148
   PubMed Web of Science ®Google Scholar
• Schur P. H., Rosen F., Norman M. E. Immunoglobulin subclasses in normal children. Pediatr. Res. 1979; 13: 181
   PubMed Web of Science ®Google Scholar
• Robbins J. B., Schneerson R., Glode M. P., Vann W., Scheffer M. S., Liu T. Y., Parke J. C., Huntley C. Cross-reactive antigens and immunity of disease caused by encapsulated bacteria. J. Allergy Clin. Immunol. 1975; 56: 141
   PubMed Web of Science ®Google Scholar
• Sutliff W. D., Davies J. A. V. A study of the origin of naturally occurring immunity for pneumococci in infants. J. Immunol. 1937; 32: 43
   Google Scholar
• Sutliff W. D., Finland M., Jackson H., Jr. Natural immunity of man to the Pneumococcus. J. Clin. Invest. 1931; 10: 660
   Google Scholar
• Goldschneider I., Gotschlich E. C., Artenstein M. S. Human immunity to the meningococcus. I. The role of humoral antibodies. J. Exp. Med. 1969; 129: 1307
   PubMed Web of Science ®Google Scholar
• Gotschlich E. C., Goldschneider I., Lepow M. L., Gold R. The immune response to bacterial polysaccharides in man. Antibodies in Human Diagnosis and Therapy, E. Haber, R. M. Krause. Raven Press, New York 1977; 391
   Google Scholar
• Heidelberger M. Cross-reactions of polysaccharides of staphylococci and streptococci in antipneumococcal and other antisera. Mol. Immunol. 1984; 21: 1011
   PubMed Web of Science ®Google Scholar
• Robbins J. B. Vaccines for the prevention of encapsulated bacterial diseases: current status, problems and prospects for the future. Immunochemistry 1978; 15: 839
   PubMedGoogle Scholar
• Barrett D. J. Human immune responses to polysaccharide antigens: an analysis of bacterial polysaccharide vaccines in infants. Adv. Pediatr. 1985; 32: 139
   PubMedGoogle Scholar
• Mosier D. E., Subbarrao B. Thymus-independent antigens: complexity of B-lymphocyte activation revealed. Immunol. Today 1982; 3: 217
   PubMedGoogle Scholar
• Baker P. J., Amsbaug D. F., Stashak P. W., Caldes G., Prescott B. Regulation of the antibody response to the pneumococcal polysaccha ride by thymus-derived cells. Rev. Infect. Dis. 1981; 3: 332
   PubMedGoogle Scholar
• Braley-Mullen H. Requirements for activation of contrasuppressor T cells by type-Ill pneumococcal polysaccharide. J. Immunol. 1986; 136: 396
   PubMed Web of Science ®Google Scholar
• Taylor C. E., Baker P. J. Production of soluble suppressor factor by spleen cells from mice immunized with type III pneumococcal polysaccharide. J. Immunol. 1985; 135: 2551
   PubMed Web of Science ®Google Scholar
• Taylor C. E., Stashak P. W., Chiang J., Leiserson W. M., Caldes G., Prescott B., Baker P. J. Characteristics of amplifier T cells involved in the antibody response to the capsular polysaccharide of type III Streptococcus pneumoniae. J. Immunol. 1984; 132: 3103
   PubMed Web of Science ®Google Scholar
• Taylor C. E., Stashak P. W., Caldes G., Prescott B., Chused T. E., Brooks A., Baker P. J. Activation of antigen-specific suppressor T cells by B cells from mice immunized with type HI pneumococcal polysaccharides. J. Exp. Med. 1983; 158: 703
   PubMed Web of Science ®Google Scholar
• Morse H. C., III, Prescott B., Cross S. S., Stashak P. W., Baker P J. Regulation of the antibody response to type III pneumococcal polysaccharide. V. Ontogeny of factors influencing the magnitude of the plaque-forming cell response. J. Immunol. 1976; 116: 279
   PubMed Web of Science ®Google Scholar
• Braley-Mullen H. Characterization and activity of contrasuppressor T cells induced by type-III pneumococcal polysaccharide. J. Immunol. 1986; 137: 2761
   PubMed Web of Science ®Google Scholar
• Bixler G. S., Jr., Pillai S. The cellular basis of the immune response to conjugate vaccines. Conjugate Vaccines, J. M. Cruse, R. E. Lewis. S. Karger, Basel 1989; 18
   Google Scholar
• Beuvery E. C., Van Rossum F., Nagel J. Comparison of the induction of immunoglobulin M and G antibodies in mice with purified pneumococcal type 3 and meningococcal group C polysaccharides and their protein conjugates. Infect. Immun. 1982; 37: 15
   PubMed Web of Science ®Google Scholar
• Robbins J. B., Austrian R., Lee C. J., Rastogi S. C., Schiffman G., Henrichsen J., Makela P. H., Broome C. V., Facklam R. R., Tiesjema R. H., Parke J. C., Jr. Consideration for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types. J. Infect. Dis. 1983; 148: 1136
   PubMed Web of Science ®Google Scholar
• Cowan M. J., Ammann A. J., Wara D. W., et al. Pneumococcal polysaccharide immunization in infants and children. Pediatrics 1978; 62: 721
   PubMed Web of Science ®Google Scholar
• Douglas R. M., Paton J. C., Duncan, Hansman D. J. Antibody response to pneumococcal vaccination in children younger than five years of age. J. Infect. Dis. 1983; 148: 131
   PubMed Web of Science ®Google Scholar
• Leinonen M., Sakkinen A., Kalliokoski R., Luotenen J., Timonen M., Makela P. H. Antibody response to 14-valent pneumococcal capsular polysaccharide vaccine in preschool age children. Pediatr. Infect. Dis. 1986; 5: 39
   PubMedGoogle Scholar
• Riley I. D., Lehmann D., Alper M. P., Marshall T. F., Gratten H., Smith D. Pneumococcal vaccine prevents death from acute lower-respiratorytract infections in Papua New Guinean children. Lancet 1986; 2: 877
   PubMed Web of Science ®Google Scholar
• Koskela M., Leinonen M., Haiva V. M., Timonen M., Makela P. H. First and second dose antibody responses to pneumococcal polysaccharide vaccine in infants. Pediatr. Infect. Dis. 1986; 5: 45
   PubMedGoogle Scholar
• Mufson M. A., Krause H. E., Schiffman G., Hughey D. F. Pneumococcal antibody levels one decade after immunization of healthy adults. Am. J. Med. Sci. 1987; 293: 279
   PubMed Web of Science ®Google Scholar
• Giebink G. S., Le C. T., Schiffman G. Decline of serum antibody in splenectomized children after vaccination with pneumococcal capsular polysaccharides. J. Pediatr. 1984; 105: 576
   PubMed Web of Science ®Google Scholar
• Weintrub P. S., Schiffman G., Addiego J. E., et al. Long-term follow-up and booster immunization with polyvalent pneumococcal polysaccharide in patients with sickle cell anemia. J. Pediatr. 1984; 105: 261
   PubMed Web of Science ®Google Scholar
• Spika J. S., Halsey N. A., Le C. T., Fish A. J., Lum G. M., Lauer B. A., Schiffman G., Giebink S. Decline of vaccine-induced anti-pneumococcal antibody in children with nephrotic syndrome. Am. J. Kidney Dis. 1986; 7: 466
   PubMed Web of Science ®Google Scholar
• Rijkers G., Kuis W., De Graeff-Meeder E., Peeters C. C., Zegers B. J. Impaired immune response to polysaccharides. N. Engl. J. Med. 1987; 317: 838
   Google Scholar
• Ambrosino D. M., Siber G. R., Chilmonczyk B. A., Jernberg J. B., Finberg R. W. An immunodeficiency characterized by impaired antibody responses to polysaccharides. N. Engl. J. Med. 1987; 316: 790
   PubMed Web of Science ®Google Scholar
• Paton J. C., Lock R. A., Lee C. J., Li J. P., Berry A. M., Michell T. J., Andrew P. W., Hansman D., Boulnois G. J. Purification and immunogenicity of genetically toxoided derivatives of pneumolysin and their conjugation to Streptococcus pneumoniae type 19F polysaccharide. Infect. Immun. 1991; 59: 2297
   PubMed Web of Science ®Google Scholar
• Mitchell T. J., Andrew P. W., Boulnois G. J., Lee C. J., Lock R. A., Paton J. C. Molecular studies of pneumolysin, the thiol-activated toxin of Streptococcus pneumoniae as an aid to vaccine design. Bact. Prot. Suppl 1992; 23: 429
   Google Scholar
• Robbins J. R., Schneerson R. Polysaccharide-protein conjugates: a new generation of vaccines. J. Infect. Dis. 1990; 161: 821
   PubMed Web of Science ®Google Scholar
• Sarnaik S., Kaplan J., Schiffman G., Bryla D., Robbins J. B., Schneerson R. Studies on pneumococcus vaccine alone or mixed with DTP and on pneumococcus type 6B and Haemophilus influenzae type b capsular polysaccharide-tetanus toxoid conjugates in 2- to 5-year-old children with sickle cell anemia. Pediatr. Infect. Dis. J. 1990; 9: 181
   PubMed Web of Science ®Google Scholar
• Dick W. E., Jr., Beurret M. Glycoconjugates of bacterial carbohydrate antigens. Conjugate Vaccines, J. M. Cruse, R. E. Lewis. S. Karger, Basel 1989; 48
   Google Scholar
• Harrison H. R., Fulginiti. Bacterial immunizations. Am. J. Dis. Child. 1980; 134: 184
   PubMedGoogle Scholar
• Insel R. A. Maternal immunization to prevent neonatal infection. N. Engl. J. Med. 1988; 319: 1219
   PubMed Web of Science ®Google Scholar
• Lee C. J., Takaoka Y., Saito T. Maternal immunization and the immune response of neonates to pneumococcal polysaccharides. Rev. Infect. Dis. 1987; 9: 494
   PubMedGoogle Scholar
• Lee C. J., Ching E. D., Vickers J. H. Maternal immunity and antibody response of neonatal mice to pneumococcal type 19F polysaccharide. J. Clin. Microbiol. 1991; 29: 1904
   PubMed Web of Science ®Google Scholar
• Lee C. J., Banks S. D., Li J. P. Virulence, immunity, and vaccine related to Streptococcus pneumoniae. Crit. Rev. Microbiol. 1991; 18(2)89
   PubMed Web of Science ®Google Scholar
• Gillespie S. H. Aspects of pneumococcal infection including bacterial virulence, host response and vaccination. J. Med. Microbiol. 1989; 28: 237
   PubMed Web of Science ®Google Scholar
• Boulnois G. J. Pneumococcal proteins and the pathogenesis of disease caused by Streptococcus pneumoniae. J. Gen. Microbiol. 1992; 138: 249
   PubMedGoogle Scholar
• Verheul A. F. M., Braat A. K., Leenhouts J. M., Hoogerhout P., Poolman J. T., Snippe H., Verhoef J. Preparation, characterization, and immunogenicity of meningococcal immunotype L2 and L3,7,9 phosphoethanolamine group-containing oli-gosaccharide-protein conjugates. Infect. Immun. 1991; 59: 843
   PubMed Web of Science ®Google Scholar
• Szu S., Lee C. J., Carlo D., Henrichsen J. Immunochemical characterization of cross-reactivity of pneumococcal group 9 capsular polysaccharide types 9N, 9A, 9L, and 9V. Infect. Immun. 1981; 31: 371
   PubMed Web of Science ®Google Scholar
• Wong K. H., Barrera O., Sutton A., May J., Hochstein D. H., Robbins J. D., Robbins J. B., Parkman P. D., Seligmann E. B., Jr. Standardization and control of meningococcal vaccines, group A and group C polysaccharides. J. Biol. Stand. 1977; 5: 197
   PubMedGoogle Scholar
• Vella P. P., Marburg S., Staub J. M., et al. Immu-nogenicity of conjugate vaccines consisting of pneumococcal capsular polysaccharide types 6B, 14, 19F, and 23F and a meningococcal outer membrane protein complex. Infect. Immun. 1992; 60: 4977
   PubMed Web of Science ®Google Scholar
• Anderson P., Betts R. Human adult immunogenicity of protein-coupled pneumococcal capsular antigens of serotypes prevalent in otitis media. Pediatr. Infect. Dis. J. 1989; 8: S50
   Web of Science ®Google Scholar
• Peeters C. C. A. M., Tenbergen-Meekes A. -M. J., Poolman J. T., Zegers B. J. M., Rijkers G. T. Immunogenicity of a Streptococcus pneumoniae type 4 polysaccharide-protein conjugate vaccine is decreased by admixture of high doses of free saccharide. Vaccine 1992; 10: 833
   PubMed Web of Science ®Google Scholar
• Bruyn G. A. W., van Furth R. Pneumococcal polysaccharide vaccines: indications, efficacy and recommendations. Eur. J. Clin. Microbiol. Infect. Dis. 1991; 10: 897
   PubMed Web of Science ®Google Scholar
• Van Dam J. E. G., Fleer A., Snippe H. Immunogenicity and immunochemistry of Streptococcus pneumoniae capsular polysaccharides. Antonie van Leeuwenhoek. J. Microbiol. Serol 1990; 58: 1
   PubMed Web of Science ®Google Scholar
• Lee C. J., Wang T. R., unpublished observation
   Google Scholar